These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35167951)

  • 61. [Travelers' vaccines].
    Ouchi K
    Nihon Rinsho; 2011 Sep; 69(9):1599-603. PubMed ID: 21922760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determinants of Compliance of Travelers with Vaccination and Malaria Prophylaxis at a Travel Clinic.
    Kwon HY; Lee H; Im JH; Park SG; Lee YJ; Baek JH; Lee JS
    J Korean Med Sci; 2019 Aug; 34(33):e217. PubMed ID: 31436051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preparing children for international travel: need for training and pediatric-focused research.
    Hagmann SH; Leshem E; Fischer PR; Stauffer WM; Barnett ED; Christenson JC
    J Travel Med; 2014; 21(6):377-83. PubMed ID: 25158953
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunization for pediatric international travelers.
    Rongkavilit C
    Pediatr Ann; 2011 Jul; 40(7):346-50. PubMed ID: 21736256
    [No Abstract]   [Full Text] [Related]  

  • 65. International Travelers' Sociodemographic, Health, and Travel Characteristics: An Italian Study.
    Troiano G; Mercone A; Bagnoli A; Nante N
    Ann Glob Health; 2017; 83(2):380-385. PubMed ID: 28619415
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modeling the elevated risk of yellow fever among travelers visiting Brazil, 2018.
    Sakamoto Y; Yamaguchi T; Yamamoto N; Nishiura H
    Theor Biol Med Model; 2018 Jul; 15(1):9. PubMed ID: 29961429
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.
    Jentes ES; Han P; Gershman MD; Rao SR; LaRocque RC; Staples JE; Ryan ET; The Global TravEpiNet Consortium
    Am J Trop Med Hyg; 2013 May; 88(5):954-961. PubMed ID: 23458961
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The elderly, the young and the pregnant traveler -- A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination.
    Jaeger VK; Tschudi N; Rüegg R; Hatz C; Bühler S
    Travel Med Infect Dis; 2015; 13(6):475-84. PubMed ID: 26526774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Global COVID-19 vaccine equity should precede requiring travelers proof of vaccination.
    Franco-Paredes C; Suarez JA; Henao-Martínez AF
    Int J Infect Dis; 2021 Apr; 105():243-244. PubMed ID: 33640569
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunization and other prophylactic measures.
    Roodyn L
    Br Med J; 1974 Dec; 4(5945):648-50. PubMed ID: 4613420
    [No Abstract]   [Full Text] [Related]  

  • 71. Vaccination in Travelers.
    Hill DR
    Curr Infect Dis Rep; 1999 Dec; 1(5):417-426. PubMed ID: 11095818
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunization for overseas travel.
    Griffith AH
    Br J Hosp Med; 1977 Jan; 17(1):7-10. PubMed ID: 402967
    [No Abstract]   [Full Text] [Related]  

  • 73. Vaccines Through Centuries: Major Cornerstones of Global Health.
    Hajj Hussein I; Chams N; Chams S; El Sayegh S; Badran R; Raad M; Gerges-Geagea A; Leone A; Jurjus A
    Front Public Health; 2015; 3():269. PubMed ID: 26636066
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models.
    Ma J; Yakass MB; Jansen S; Malengier-Devlies B; Van Looveren D; Sanchez-Felipe L; Vercruysse T; Weynand B; Javarappa MPA; Quaye O; Matthys P; Roskams T; Neyts J; Thibaut HJ; Dallmeier K
    EBioMedicine; 2022 Sep; 83():104240. PubMed ID: 36041265
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Travel medicine consultation: An opportunity to improve coverage for routine vaccinations.
    Aba YT; Gagneux-Brunon A; Andrillat C; Fouilloux P; Daoud F; Defontaine C; Lucht F; Botelho-Nevers E
    Med Mal Infect; 2019 Jun; 49(4):257-263. PubMed ID: 30583868
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Side effects of travel vaccinations. Data collection via telephone survey in Berlin].
    Philipps J; Schönfeld C; Schleehauf DM; Beuerle W; Bienzle U; Kremsner PG
    Wien Klin Wochenschr; 1996; 108(19):615-20. PubMed ID: 9012147
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of yellow fever vaccination practice in England.
    Bryant N; Tucker R; Simons H; Bailey S; Mathewson J; Lea G; Hill DR
    J Travel Med; 2008; 15(5):287-93. PubMed ID: 19006500
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
    Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Supporting Tourism by Assessing the Predictors of COVID-19 Vaccination for Travel Reasons.
    Morar C; Tiba A; Jovanovic T; Valjarević A; Ripp M; Vujičić MD; Stankov U; Basarin B; Ratković R; Popović M; Nagy G; Boros L; Lukić T
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of travel medicine practice by yellow fever vaccination centers in England, Wales, and Northern Ireland.
    Boddington NL; Simons H; Launders N; Gawthrop M; Stillwell A; Wong C; Mathewson J; Hill DR
    J Travel Med; 2012; 19(2):84-91. PubMed ID: 22414032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.